Eudralex Volume 3 CHMP/CAT position statement on Creutzfeldt-Jakob disease and advanced therapy medicinal products

Titel:
Eudralex Volume 3 CHMP/CAT position statement on Creutzfeldt-Jakob disease and advanced therapy medicinal products
Herkunft/Verlag:

European Commission Enterprise and Industry DG, BREY 13/ 092, B - 1049 Brussels (Belgium), http://ec.europa.eu/enterprise/

Dokumentenart:
Draft Guideline
Inhalt:
Aktueller Stand der betreffenden Guidelines für Neuartige Therapien

Zurück

GMP Seminare nach Thema